Видео

AstraZeneca has released a new episode of its recently launched TrailblAZers video podcast featuring New Zealand MP Todd Stephenson.

Rare Cancers Australia founder and CEO Richard Vines sat down for a discussion with BioPharmaDispatch. He challenged the early direction of the health technology assessment review and called on health minister Mark Butler to set clear expectations for the process while saying it cannot be credibly conducted behind closed doors.

Pfizer managing director Anne Harris spoke with BioPharmaDispatch about the recent launch of the company's Reflect Reconciliation Action Plan.

Medicines Australia CEO Liz de Somer spoke with BioPharmaDispatch about Budget 2020-21, the medicines guarantee, cost-offsets and the negotiation of a new agreement.

The AbbVie Australia boss sat for a recorded interview to discuss recognition for the company, change as a result of COVID-19 and what it might mean for the future workplace.

BioPharmaDispatch spoke with Roche general manager and Medicines Australia board member Stuart Knight on the company's recently announced 'transformation'.

The industry is working in "close collaboration" with government and research institutes globally on the development of treatments and vaccines for COVID-19, according to Medicines Australia chief executive Liz de Somer.

Medicines Australia and the Generic and Biosimilar Medicines Association have shared how they will work together to coordinate supply under their recent ACCC authorisation while the MA boss also discusses recent challenges and the importance of international freight.

Merck BioPharma Australia at their new Macquarie Park office

AZ's Pascal Soriot: 'My Australia and the new AstraZeneca'

Recently appointed CEO of AusBiotech, Lorraine Chiroiu, says the association plans to build its role in policy to help ensure the operating environment supports the continued growth of the sector.

Recently appointed CEO of AusBiotech, Lorraine Chiroiu, says the association plans to build its role in policy to help ensure the operating environment supports the continued growth of the sector.

Carlo Montagner, co-founder and CEO of Specialised Therapeutics

In a wide-ranging interview with PharmaDispatch, AstraZeneca's Liz Chatwin talks about how the Australian market has changed, the opportunity for industry to be more strategic on key issues, manufacturing and R&D, and diversity.

Pfizer's journey to the CBD begins (full length)

Pfizer's 'journey' to the CBD begins

Working at AbbVie in 2017

Alastair Furnival, principal, Evaluate

Ian Burgess, CEO, Medical Technology Association of Australia

Brian Gladsden, country president and managing director, Novartis Australia and New Zealand

Paul Spittle, country president, AstraZeneca Australia and New Zealand

Melissa McGregor, managing director, Pfizer Australia

Tony Hooper, executive vice president and head of global commercial operations, Amgen

Christian Sellars, director market access, public affairs and customer centricity, MSD

Richard Vines and PBAC chair Professor Andrew Wilson

Dr Rachel David, CEO, Private Healthcare Australia

Dr Rachel David, CEO, Private Healthcare Australia

Dr Paul Cornes